ArticleProceedings of the National Academy of Sciences of the United States of America2018

PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer.

David de Semir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.